Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Release potency tests of hepatitis vaccines.

J Descamps1, A Mary, E Rommel

  • 1SmithKline Beecham Biologicals, Rixensart, Belgium.

Developments in Biological Standardization
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of climate and demographic changes on future mortality in Brussels, Belgium.

Public health·2024
Same author

Light Conversion by Electrochemiluminescence at Semiconductor Surfaces.

Accounts of chemical research·2024
Same author

Sleep and memory consolidation in aging: A neuroimaging perspective.

Revue neurologique·2023
Same author

[First French-speaking days of users of decision support system in clinical pharmacy: Feedback and perspectives].

Annales pharmaceutiques francaises·2023
Same author

Changes in electrophysiological static and dynamic human brain functional architecture from childhood to late adulthood.

Scientific reports·2020
Same author

Management of osteomeningeal defects in a case of lung adenocarcinoma with metastasis.

Neuro-Chirurgie·2020
Same journal

International challenges and public policy issues.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000
Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000
Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000
Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000
Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000
See all related articles

SmithKline Beecham Biologicals transitioned to in vitro potency testing for hepatitis A and B vaccines. This shift significantly reduced animal use in vaccine release processes.

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • SmithKline Beecham Biologicals developed vaccines for hepatitis A (Havrix, 1991) and hepatitis B (Engerix-B, 1986).
  • Traditional vaccine release relied heavily on animal testing for potency assessment.

Purpose of the Study:

  • To demonstrate the transition to in vitro potency testing for hepatitis vaccines.
  • To highlight the reduction in animal usage for vaccine release.

Main Methods:

  • Case study analysis of hepatitis A and B vaccine development and release.
  • Evaluation of the implementation of in vitro potency assays.

Main Results:

  • The transition to in vitro release testing for vaccine potency was a gradual process.

Related Experiment Videos

  • Significant reduction in the number of animals required for vaccine release was achieved.

    • Conclusions:

    • In vitro potency testing offers a viable and ethical alternative to animal testing for vaccine release.
    • The successful implementation of these methods for hepatitis vaccines demonstrates a pathway for other biological products.